| Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210) |
|---|
| 09/14/2005 | CN1219055C A specific proliferation in tumour cell which can express antioncogene with high efficiency and the use of it |
| 09/14/2005 | CN1219054C Structure for recombinant adenovirus with double killer function and application in tumor treatment |
| 09/14/2005 | CN1219050C Transgenic saline algae bio-reactor |
| 09/14/2005 | CN1218961C Osteoclast formation inhibitive factor, its nucleotide sequence and preparation method |
| 09/14/2005 | CN1218959C Paddy rice ethylene receptor protein, coded gene and use thereof |
| 09/14/2005 | CN1218954C Human hematopoietic cell relative gene-1 |
| 09/14/2005 | CN1218749C Recombination protein vaccine for preventing animal aphtha virus infection and uses thereof |
| 09/13/2005 | US6943345 Soft ionization device and applications thereof |
| 09/13/2005 | US6943282 Insect resistant plants |
| 09/13/2005 | US6943281 Expression of Cry3B insecticidal protein in plants |
| 09/13/2005 | US6943280 Comprises nucleotide sequences coding acetolactate synthase for propagation of herbicide resistant plants |
| 09/13/2005 | US6943278 Genetically engineered flies for identifying and treating neuroegenerative diseases |
| 09/13/2005 | US6943277 Transgenic mice containing stefin homolog protease inhibitor gene disruptions |
| 09/13/2005 | US6943246 3′terminal sequence of hepatitis C virus genome and diagnostic and therapeutic uses thereof |
| 09/13/2005 | US6943245 Gene for which is located on the short arm of human chromosome 1; gene is directly implicated in colon, kidney and breast cancers |
| 09/13/2005 | US6943244 Human g-type lysozyme, the encoding sequence, preparing method and the uses thereof |
| 09/13/2005 | US6943243 Control of gene expression in eukaryotic cells |
| 09/13/2005 | US6943242 Design of artificial genes for use as controls in gene expression analysis systems |
| 09/13/2005 | US6943241 Full-length cDNA |
| 09/13/2005 | US6943240 Nucleic acids for high throughput screening of CpG-based immuno-agonist/antagonist |
| 09/13/2005 | US6943239 Antigenic fusionprotein carrying Galα1,3Gal epitopes |
| 09/13/2005 | US6943238 Antibodies to cyclin E2 protein |
| 09/13/2005 | US6943237 GANP protein |
| 09/13/2005 | US6943234 Pichia methanolica secretory signal |
| 09/13/2005 | US6943152 DNA vaccine-PCV |
| 09/13/2005 | US6943151 Method of inhibiting bone resorption and/or promoting bone formation using GLP-2 and related compounds |
| 09/13/2005 | US6943150 Antiapoptosis polypeptides or fusion proteins coded by nucleic acids |
| 09/13/2005 | US6943028 Controlling, activating gene operon promoter, induced by aromatic carboxylic acids in bacteria host cell, for industrial scale biosynthesis, expression a heterologous nucleic acid, encoded protein for enzymatic biosynthetic pathway |
| 09/13/2005 | US6943026 A mixture of first and second nucleic acid constructs, is used for gene therapy, as antitumor agents, antiproliferative agents, suppressed by a wild-type p53 allele in non-tumour cells relative to tumor cells, prodrug activating thymidine kinase |
| 09/13/2005 | US6943025 Using fish models; cancer therapy |
| 09/13/2005 | US6943022 Inhibition of apoptosis by the expression of antisense RNA of caspase-3 |
| 09/13/2005 | US6943021 Three dimensional vaginal tissue model containing immune cells |
| 09/13/2005 | US6943020 Death domain containing receptor-4 antibodies |
| 09/13/2005 | US6943019 Methods and vector constructs useful for production of recombinant AAV |
| 09/13/2005 | US6943018 Transgenic expression from a SOCS-3 promoter in vertebrate cells |
| 09/13/2005 | US6943017 Transforming the organism (Lovastatin producing organism) with the D4B segment of aspergillus terreus, wherein the segment is transcribed and translated, and wherein an increase in lovastatin production occurs |
| 09/13/2005 | US6943016 incubating a mixture of astrocytes and glial cells from patient surgical resection, culturing, astrocytes joining to the culture vessel, removing the un-attached cells; purification; treating CNS trauma, neurodegenerative disorders |
| 09/13/2005 | US6943015 Large scale production of packaged alphavirus replicons |
| 09/13/2005 | US6943014 Invention provides cDNAs encoding deoxyribonuclease II beta and isolated, purified deoxyribonuclease II beta proteins and antibodies against this protein and antisense agents targeted to cDNA or mRNA encoding deoxyribonuclease II beta |
| 09/13/2005 | US6943013 DNA expression vector; host cell transformed, transfected or infected with the vector; transgenic cell, tissue or organism; HCDS1 protein |
| 09/13/2005 | US6943012 Helper dependent adenoviral vector system and methods for using the same |
| 09/13/2005 | US6943010 Inhibiting gene expression of allegen protein, isolated polynucleotide molecule comprising a peanut allergen antisense gene, homologous region is operably linked to a promoter, cloning, transforming a plant cell with vector |
| 09/13/2005 | US6943006 Method for metabolizing carbazole in petroleum |
| 09/13/2005 | US6943004 A zinc resist Alcaligenes microorganism, culturing in presence of zinc, isolated nucleic acid sequence, vectors, zinc-resistant host cell; high production rate; enzyme has optical purity, used for making antibiotics, peptide drug |
| 09/13/2005 | US6943003 Isolate nucleic acid, vectors, host cell containing the vector, therapeutic agents as modulators of the phospholipase peptides, which can be expressed in human tissure, promoting digestion and metabolism of phospholipids |
| 09/13/2005 | US6943002 Preparation of deallergenized proteins and permuteins |
| 09/13/2005 | US6943000 Detection of modulator of enzyme activity; obtain cells, incubate with modulator, monitor adjustment in enzyme activity, adjustment in activity indicates modulator |
| 09/13/2005 | US6942999 Isolated human enzyme proteins, nucleic acid molecules encoding human enzyme proteins, and uses thereof |
| 09/13/2005 | US6942995 Expression vector for use as tool in genome analysis |
| 09/13/2005 | US6942994 Lyases; plastidic synthetases; pyruvate dehydrogenase/ decarboxylase, aldehyde dehydrogenase; fatty acid biosynthesis; chloroplast photochemistry |
| 09/13/2005 | US6942992 Nucleic acid sequences encoding human slit-, megf-, and roundabout-like polypeptides |
| 09/13/2005 | US6942991 Nucleotide sequences coding for polypeptides endowed with a larvicidal activity towards Lepidoptera |
| 09/13/2005 | US6942990 Glutaryl cephalosporin amidase from Pseudomonas diminuta BS-203 |
| 09/13/2005 | US6942984 Used to treat apoptotic disorder like cancer, autoimmune disorder, viral infections, Alzheimer's disease, Parkinson's disease or aplastic anemia; treats inflammatory disorders like arthritis, Crohn's disease, psoriasis, allergy or asthma |
| 09/13/2005 | US6942983 An isolated monoclonal antibody is used for binding and detecting a polypeptide having amino acid sequence with valine at residue 835, modulate kinase activity in cells, protein kinase C |
| 09/13/2005 | US6942982 FEBP1 protein vector host cells and method for making FEBP1 protein |
| 09/13/2005 | US6942979 Method for screening substances capable of modulating the activity of a TRAAK potassium channel |
| 09/13/2005 | US6942975 Methods and kits for obtaining DNA end sequence information for large cloned inserts and uses thereof |
| 09/13/2005 | US6942973 Isolation of gene expressing preferential polypeptide; obtain nucleotide sequences, incubate with probes, monitor gene expression isolatea gene from microorganism |
| 09/13/2005 | US6942969 Compositions and methods for determining anti-viral drug susceptibility and resistance and anti-viral drug screening |
| 09/13/2005 | US6942967 Drug screening an apoenzyme inhibitor, for use as antidiabetic agent, antilipemic agent, hypoglycemic agent; incubating a synthetic RNA sequence, adding reverse transcriptase and a radiolabelled nucleotide, detecting the absence of deamination |
| 09/13/2005 | US6942965 Hepatitis A virus nucleotide sequences, recombinant proteins and uses thereof |
| 09/13/2005 | US6942866 Hepatitis viral protein for use in treatment of viral diseases |
| 09/13/2005 | US6942864 use of live, recombinant leporipox virus comprising exogenous DNA, which is operably linked to at least one expression control element and which is incorporated into non-essential region of virus genome, in manufacture of vector vaccine |
| 09/13/2005 | US6942863 Polypeptide for use the prevention of infections associated with tissue grafting |
| 09/13/2005 | US6942861 Functional bacterial protein, intimin, and its use as an antigen for protecting against infection by or transmission of bacteria expressing intimin-like proteins, such as certain pathogenic strains of Escherichial coli |
| 09/13/2005 | US6942855 recombinant vaccinia virus having a deletion of the region encoding the C-terminal seven amino acids of the E3L gene product and comprising exogenous DNA; use in genetic vaccines for example |
| 09/13/2005 | US6942854 Orally-administered interferon-tau compositions and methods |
| 09/13/2005 | US6942853 Latent fusion protein |
| 09/13/2005 | US6942837 System for filling a substrate with a liquid sample |
| 09/13/2005 | US6942771 Microfluidic systems in the electrochemical detection of target analytes |
| 09/13/2005 | CA2261930C Frozen confectionery products |
| 09/13/2005 | CA2218299C Bacteria having nematicidal activity and their agricultural use |
| 09/13/2005 | CA2213991C Cold-inducible promoter sequence |
| 09/13/2005 | CA2186164C Methods for producing cytoplasmic male sterility in plants and use thereof in production of hybrid seed |
| 09/13/2005 | CA2175476C Opioid receptor: compositions and methods |
| 09/13/2005 | CA2123686C Method for exponential amplification of nucleic acid by a single unpaired primer |
| 09/13/2005 | CA2106315C Gene construct for production of transgenic fish |
| 09/13/2005 | CA2067909C Homogeneous methods for nucleic acid amplification and detection |
| 09/12/2005 | CA2497799A1 Acetolactate synthase gene promoter |
| 09/12/2005 | CA2460873A1 Inhibitors of siderophore biosynthesis in fungi |
| 09/10/2005 | CA2500033A1 Methods for isolation of bacteria from biological samples |
| 09/09/2005 | WO2005083448A1 Substrate for microarray of biomolecule, hybridization device, and hybridization method |
| 09/09/2005 | WO2005083124A1 Antisense oligonucleotide modulation of stat3 expression |
| 09/09/2005 | WO2005083119A2 Hybridization method as well as hybridization microarray and hybridization kit |
| 09/09/2005 | WO2005083112A1 Method for screening h-type rnase inhibitor of reverse transcriptase |
| 09/09/2005 | WO2005083108A1 Reduction of spontaneous mutation rates in cells |
| 09/09/2005 | WO2005083104A1 Method of producing liquid cell extract for cell-free protein synthesis |
| 09/09/2005 | WO2005083098A1 Recombinant perforin, expression and uses thereof |
| 09/09/2005 | WO2005083097A1 A method for creating myeloid cell lines |
| 09/09/2005 | WO2005083096A1 Plants modified with mini-chromosomes |
| 09/09/2005 | WO2005083095A2 Methods for enhancing insect resistance in plants |
| 09/09/2005 | WO2005083094A2 Plants having increased yield and method for making the same |
| 09/09/2005 | WO2005083092A2 Transposon from aspergillus fumatigus and mutagenesis therewith |
| 09/09/2005 | WO2005083091A1 Culture device and method for eukaryotic cell transfection |
| 09/09/2005 | WO2005083090A1 Method of inducing homologous recombination |
| 09/09/2005 | WO2005083089A1 Gamma-butyrobetaine hydroxylase originated from neurospora crassa |
| 09/09/2005 | WO2005083087A1 Transgennic animal allowing inductive deletion of osteocytes |
| 09/09/2005 | WO2005083086A2 Epha4 as therapeutic target of prc and pdaca |
| 09/09/2005 | WO2005083085A1 Treatment of hyperproliferative disease |